About | Scailyte

Extracting knowledge from single-cell data to save millions of lives

A new and emerging type of analytical devices produce rich data-sets by measuring hundreds of parameters from millions of individual cells. The resulting single-cell data holds the information needed for early disease detection, but it requires sophisticated and innovative computational approaches in order to extract the relevant information.

We address this problem by developing artificial intelligence (AI) software for single-cell data analysis. The underlying algorithms allow us to associate patterns in single-cell data with disease status, similar to how state-of-the-art methods for object recognition associate pixel patterns with objects. We provide a software solution (ScaiVision), wrapping our AI technology for R&D customers from academia, pharmaceutical and clinics.

We expose complex diseases with high precision at an early stage to improve and save lives.

Dr. Peter Nestorov

Founder & Chief Executive Officer

Peter holds a PhD in Genetics from the University of Basel and a degree in Biochemistry from the University of Tübingen. He has been working in the emerging single-cell analysis market since 2015 and this gave him the inspiration to start Scailyte as co-founder and CEO in 2017.

Dr. Vijay Tiwari

Director Biomarker Discovery

Vijay gained a PhD in Genetics from Uppsala University, Sweden and following training at the Johns Hopkins University, USA and Friedrich Miescher Institute in Basel, Switzerland, he has led a biomedical research group at the Institute of Molecular Biology in Germany before joining Scailyte in 2018.

Dr. Sarah Carl

Director Data Science

Sarah holds a PhD in Genetics from the University of Cambridge. She worked as a bioinformatician at the Friedrich Miescher Institute in Basel, Switzerland, for four years before joining Scailyte. Sarah joined Scailyte as a data scientist in 2018 and has been recently promoted to become Director of Data Science.

Stefan Almestrand

Director Corporate Development

Stefan has a Master’s degree in Chemical and Biotech Engineering. He has 10+ years experience holding various European and Global commercial roles in diagnostic and pharmaceutical companies. Stefan joined Scailyte in 2018

Anna Dimitrova, ACCA

Director Finance & Operations

Anna is an ACCA graduate with a Master’s degree in Finance and Banking from Sofia University. Previously, she worked as a finance manager in a fast growing company, auditor in KPMG and business consultant in PwC. Anna joined the Scailyte team in 2018.

Prof. Dr. Manfred Claassen

Founder & Chief Scientific Advisor AI & Single-Cell Analysis

He holds degrees in both Biochemistry and Computer Science from the University of Tübingen and a PhD in the design and validation of proteome measurements from the ETH Zurich.

Prof. Dr. Michael Mueller, MD

Clinical Advisor Endometriosis

is a renowned gynecologist and gynecological oncologist, and managing director of the Women’s Health Clinic at the University Hospital of Bern (Inselspital). Prof. Mueller is supporting Scailyte as a clinical advisor and expert in endometriosis and women’s health.

Read bio

Prof. Dr. Petter Brodin, MD

is a pioneer in single-cell analysis and, advising Scailyte in immunology and the application of single-cell technologies for clinical research. Prof. Brodin is based at the Karolinska Institute in Sweden and heads a research group that focuses on systems-level analyses of the human immune system. Prof. Brodin is a consultant pediatrician working at the Karolinska University Hospital.

Read bio

Prof. Dr. Emmanuella Guenova, MD

Clinical Advisor CTCL & Immunology

is a dermatologist, specialist in cutaneous lymphoma and laboratory diagnostics of skin diseases, and appointed professor at the Faculty of Biology and Medicine of the University of Lausanne.

Dr. Michael Stadler

received training in immunology and bioinformatics from the Universities of Lausanne and Geneva. He is a scientific advisor supporting Scailyte’s with the development of our data analytics platform.

Prof. Dr. Tomas Kalina MD

Scientific Advisor Flow Cytometry & Immuno assays

is a physician and a cytometry expert currently leading a research group focused on disorders of adaptive immunity at the Charles University in Prague. Professor Kalina is supporting Scailyte as a clinical diagnostic advisor with his expertise in cytometry standardization.

Read bio

Pascal Winnen

CEO Hemex AG & Scailyte Board of Directors

Pascal is a co-founder and the CEO of HEMEX, a pharmaceutical, biotech and medical device consulting firm with offices in Switzerland, Germany and the USA.

Dominique Mégret

Head of Swisscom Ventures & Scailyte Board of Directors

Dominique Mégret is head of Swisscom Ventures, which he started in 2007. He joined Swisscom in 2002 as head of the Group Strategy unit.

Join the Scailyte team
Are you ready to help us transform biomedical research and healthcare? Please send us your CV, and your letter of motivation to join Scailyte, in an email to: careers@scailyte.com

In our mission to discover complex diseases patterns through single-cell data, we are looking for bright, passionate, and dedicated individuals who share our values of dream big, make it happen and strive for qiality to join our growing energetic & fun team. We offer flexible working schedule and home-office options.

Recent News

Scailyte participates @ swissnex san francisco DEMO DAY!

Striving to internationalize and network, Scailyte participates and pitches at the swissnex Demo Day

Scailyte Q3 2020 Update

Q3 2020 update on Scailyte's progress towards its mission to save millions of lives.

ETH Industry E-Week 2020 features Scailyte with the headline: Using Artificial Intelligence to unlock the clinical potential of single-cell data.

As ETH- Spin-off Scailyte attends the 2020 Industry eWeek giving updates on the disease area focus,

Scailyte closed today their pre-series A financing with Investiere as an additional investor

Interview with Scailyte’s CEO Peter Nestorov

In the interview done by Venturelab, Peter talks about the challenges of an entrepreneur. As the CEO

Interview with Scailyte Founder Prof. Dr. Manfred Claassen

In an interview with Investiere our founder and scientific advisor Prof. Dr. Manfred Claassen descri

Scailyte: simplifying difficult diagnoses

Making a diagnosis can be a tricky endeavour. For instance, diagnosing skin T-cell lymphoma, a rare

Scailyte among The Spinoff Prize finalists

Scailyte is among the ten selected young science-based university spinoff companies that showcase th

Recent News

01 /04

Scailyte participates @ swissnex san francisco DEMO DAY!

Striving to internationalize and network, Scailyte participates and pitches at the swissnex Demo Day

Scailyte Q3 2020 Update

Q3 2020 update on Scailyte's progress towards its mission to save millions of lives.

Recent News

02 /04

ETH Industry E-Week 2020 features Scailyte with the headline: Using Artificial Intelligence to unlock the clinical potential of single-cell data.

As ETH- Spin-off Scailyte attends the 2020 Industry eWeek giving updates on the disease area focus,

Scailyte closed today their pre-series A financing with Investiere as an additional investor

Recent News

03 /04

Interview with Scailyte’s CEO Peter Nestorov

In the interview done by Venturelab, Peter talks about the challenges of an entrepreneur. As the CEO

Interview with Scailyte Founder Prof. Dr. Manfred Claassen

In an interview with Investiere our founder and scientific advisor Prof. Dr. Manfred Claassen descri

Recent News

04 /04

Scailyte: simplifying difficult diagnoses

Making a diagnosis can be a tricky endeavour. For instance, diagnosing skin T-cell lymphoma, a rare

Scailyte among The Spinoff Prize finalists

Scailyte is among the ten selected young science-based university spinoff companies that showcase th

Our mission is to develop the next generation diagnostics using single-cell analysis to save lives

About us

Vision